8-K: SinglePoint Inc. Faces Delisting from Cboe BZX Exchange After Appeal Denial

SinglePoint Inc. has been notified that its common stock will be suspended and delisted from the Cboe BZX Exchange after the denial of their request for an extension to meet listing requirements.

Summary

• SinglePoint Inc. received notice from the Cboe BZX Exchange that its request for an extension to meet continued listing requirements was denied.
• The Cboe BZX Hearings Panel affirmed the previous delisting determination due to deficiencies in meeting listing rules 14.6(c)(1), 14.9(e)(1)(B), and 14.9(e)(2).
• Trading of SinglePoint's common stock will be suspended after the close of trading on September 10, 2024.
• The company has 15 calendar days to appeal the decision, but an appeal will not prevent the suspension of trading.
• If no appeal is made, the company's stock will be delisted from the Cboe BZX.
• SinglePoint anticipates its stock will be eligible for quotation on the OTC Markets after delisting.

Sentiment

Score: 3

Explanation: The document conveys negative news regarding the delisting of the company's stock, which is a significant setback. While the company states it does not expect an impact on day-to-day operations, the delisting is a negative event.

Positives

• The company does not expect the delisting to impact its day-to-day operations.
• SinglePoint anticipates its common stock will be eligible to be quoted on the OTC Markets following delisting.

Negatives

• SinglePoint's request for an extension to meet listing requirements was denied.
• The company's common stock will be suspended and delisted from the Cboe BZX Exchange.
• An appeal will not prevent the suspension of trading.

Risks

• The delisting from the Cboe BZX could negatively impact investor confidence and stock price.
• Trading on the OTC Markets may result in lower liquidity and visibility for the stock.
• The company faces the risk of not being able to meet future listing requirements on other exchanges.

Future Outlook

The company anticipates its common stock will be eligible to be quoted on the OTC Markets following delisting from the Cboe BZX. The company is considering whether to appeal the delisting decision.

Management Comments

• The company does not expect the Panel's decision to have any impact on its day-to-day operations.

Industry Context

Delisting from a major exchange like Cboe BZX can be a significant setback for a company, potentially impacting its access to capital and investor confidence. Companies facing delisting often seek to trade on over-the-counter markets as an alternative.

Comparison to Industry Standards

• Companies like SinglePoint that fail to meet listing requirements of major exchanges such as Cboe BZX often face delisting.
• Many companies that are delisted from major exchanges move to the OTC markets, which is a common path for companies that do not meet the listing requirements of major exchanges.
• The delisting process is standard and follows the rules of the exchange, which is similar to other companies that have faced delisting.

Stakeholder Impact

• Shareholders may experience a decrease in the value of their investment due to the delisting.
• Employees may be concerned about the company's future prospects.
• Customers and suppliers may have concerns about the company's stability.

Next Steps

• The company will decide whether to appeal the delisting decision within 15 calendar days.
• The company's stock will be suspended from trading on the Cboe BZX after the close of trading on September 10, 2024.
• The company anticipates its stock will be eligible for quotation on the OTC Markets after delisting.

Key Dates

Keywords

delisting, Cboe BZX, stock suspension, OTC Markets, listing requirements, appeal, trading suspension